---

Market Overview

---

The Europe vaccine packaging market exhibited a value of $1,016.6 million in 2022 and is expected to reach $1,487.4 million by 2028, with a compound annual growth rate (CAGR) of 6.55% during the study period.

Vaccine packaging plays a crucial role in securely packaging vaccines to maintain their therapeutic potency for a specific duration. It encompasses various packaging components such as vials, ampoules, prefilled syringes, and bags & pouches, serving as the primary level of packaging.

The European vaccine packaging market is experiencing significant growth attributed to several factors. These include increased research and development (R&D) activities in response to the prevalence of diverse infectious diseases, the presence of leading vaccine players in the region, well-developed infrastructure supporting the healthcare industry, substantial investments in drug development, and growing government initiatives aimed at promoting vaccination campaigns and public health.

As a result of these favorable conditions, the vaccine packaging market in Europe is poised for continued expansion in the coming years.

---

Market Segmentation

---

The market is segmented based on various factors, including packaging level, packaging type, material type, end-user type, and region.

Segmentation by Packaging Level
Primary
Secondary
Tertiary

Segmentation by Packaging Type
Vials
Ampoules
Syringes
Others

Segmentation by Material Type
Glass
Plastic
Others

Segmentation by End-user Type
Pharmaceuticals & Biotech Companies
Healthcare Facilities
Others

Segmentation by Region
Eu5- Germany, France, UK, Italy, Spain
Central & Eastern Europe – Poland, Netherlands, Switzerland
Nordic Countries – Sweden, Denmark

The primary packaging segment holds the largest share, surpassing 71%, in Europe’s vaccine packaging market. This is primarily driven by the increasing demand for vials, ampoules, and syringes due to the growing need for vaccines.

Among the different types of primary packaging, vials packaging captures the majority market share in the Europe vaccine packaging market, accounting for 38.18%. This dominance can be attributed to the widespread utilization of vials as essential primary packaging components for vaccine products.

In terms of material type, glass emerges as the leading segment, capturing a share of 44.09% in the Europe vaccine packaging market. This can be attributed to the external barrier properties of glass and its high demand for primary packaging purposes.

Within the Europe vaccine packaging market, pharmaceutical and biotech companies hold the largest share, exceeding 46%. This growth is propelled by factors such as the rise in contagious or infectious diseases, the aging population, and the increasing demand for vaccines. Furthermore, innovations in vaccine development have further spurred the growth of the vaccine packaging industry.

In 2022, the EU5 countries (United Kingdom, Germany, France, Italy, Spain) dominate the vaccine packaging market, holding the highest revenue share of 53.76%. Central and Eastern Europe follow with a share of 35.37%, while the Nordic countries account for 10.87% of the market share.

---

Competitive Landscape

---

The competitive landscape in the European vaccine packaging market is becoming increasingly intense, as global players offer a wide range of products. Currently, several companies dominate the vaccine packaging market in Europe, including SCHOTT, Gerresheimer AG, Stevanato Group, Amcor, SGD Pharma, WestRock, Corning Incorporation, and others.

Key companies profiled in this report include SCHOTT Pharma, Gerresheimers AG, Stevanato Group, SGD Pharma, WestRock Pharma, Amcor, Aptar Group, Corning International, Catalent, Becton, Dickinson and company (BD), Panasonic Health Corporation, Cognex, Airnov, Bilcare Research, DHL, Borosil, CCL, Drug Plastics Group, DWK Life Sciences, LOG, Eppendorf, Renolit, Qorpak, Nipro, Medical Packaging LLC.

---

Key Questions Answered

---

What was the market size of the vaccine packaging market in Europe in 2022?

What are the significant trends influencing the growth of the vaccine packaging market in Europe?

Who are the key players in the vaccine packaging market in Europe?

Which packaging type segment holds the largest market share in the vaccine packaging market in Europe?

Which European country has the highest market share in the vaccine packaging market in Europe?

How is each segment of the vaccine packaging market expected to grow during the forecast period?

What will be the compound annual growth rate (CAGR) of the vaccine packaging market in Europe during the forecast period?

Which primary packaging type holds a stronger market share in the vaccine packaging market in Europe?

What is the major end-user type segment in the vaccine packaging market in Europe?

What are the driving factors, restraints, and opportunities in the vaccine packaging market in Europe?